Torrent Pharmaceuticals Promoter Sells 2.9% Stake for Rs 3,086 Crore
By Rediff Money Desk, New Delhi Oct 30, 2024 21:03
Torrent Investments, a promoter entity of Torrent Pharmaceuticals, has sold a 2.9% stake in the company for Rs 3,086 crore through open market transactions. The shares were sold in the price range of Rs 3,103.07-3,104.40 apiece.
New Delhi, Oct 30 (PTI) Torrent Investments, a promoter entity of Torrent Pharmaceuticals, on Wednesday trimmed a 2.9 per cent stake in the company for Rs 3,086 crore through open market transactions.
According to the bulk deal data available with the BSE, Torrent Investments Pvt Ltd sold a total of 99.44 lakh shares or 2.94 per cent stake in Torrent Pharmaceuticals.
The shares were sold in the price range of Rs 3,103.07-3,104.40 apiece, taking the combined transaction value to Rs 3,086.37 crore.
After the stake sale, the combined holding of promoters of Torrent Pharmaceuticals has come down to 68.31 per cent from 71.25 per cent.
Details of the buyers of Torrent Pharmaceuticals' shares could not be ascertained on the BSE.
Last week, Torrent Pharmaceuticals reported its consolidated profit after tax rose 17 per cent to Rs 453 crore in the September quarter, led by robust sales in the domestic market.
The drug firm had reported a profit after tax (PAT) of Rs 386 crore in the July-September period of the last fiscal.
During the period under review, revenues rose to Rs 2,889 crore compared to Rs 2,660 crore in the year-ago period.
The company said its India revenues increased 13 per cent to Rs 1,632 crore, led by outperformance in focus therapies, it added.
Shares of Torrent Pharmaceuticals fell 2.30 per cent to close at Rs 3,137.15 apiece on the BSE on Wednesday.
According to the bulk deal data available with the BSE, Torrent Investments Pvt Ltd sold a total of 99.44 lakh shares or 2.94 per cent stake in Torrent Pharmaceuticals.
The shares were sold in the price range of Rs 3,103.07-3,104.40 apiece, taking the combined transaction value to Rs 3,086.37 crore.
After the stake sale, the combined holding of promoters of Torrent Pharmaceuticals has come down to 68.31 per cent from 71.25 per cent.
Details of the buyers of Torrent Pharmaceuticals' shares could not be ascertained on the BSE.
Last week, Torrent Pharmaceuticals reported its consolidated profit after tax rose 17 per cent to Rs 453 crore in the September quarter, led by robust sales in the domestic market.
The drug firm had reported a profit after tax (PAT) of Rs 386 crore in the July-September period of the last fiscal.
During the period under review, revenues rose to Rs 2,889 crore compared to Rs 2,660 crore in the year-ago period.
The company said its India revenues increased 13 per cent to Rs 1,632 crore, led by outperformance in focus therapies, it added.
Shares of Torrent Pharmaceuticals fell 2.30 per cent to close at Rs 3,137.15 apiece on the BSE on Wednesday.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Kretto Syscon
- 1.03 ( -4.63)
- 138373597
- Thinkink Picturez
- 2.03 (+ 4.64)
- 77082948
- Rajnish Wellness
- 1.86 (+ 4.49)
- 51273863
- Vodafone Idea L
- 8.08 ( -0.25)
- 43651174
- Srestha Finvest
- 0.94 (+ 9.30)
- 39839348
MORE NEWS
Sai Life Sciences IPO: Rs 913 Crore from Anchor...
Sai Life Sciences, backed by TPG Capital, raised Rs 913 crore from anchor investors...
Adani to Self-Fund Colombo Port Project,...
Adani Ports will use its own resources for the Colombo West International Terminal,...
Gadkari Announces Rs 30,000 Crore Road Projects...
Union Minister Nitin Gadkari announced Rs 30,000 crore road projects for Rajasthan,...